THECA consortium begins Vi-TT typhoid conjugate vaccine phase IV effectiveness study in Ghana
SEOUL, RE, July 26, 2021 /EINPresswire.com/ -- The International Vaccine Institute (IVI) announced today the start of a cluster-randomized, controlled Phase IV trial to assess the effectiveness of Typbar® typhoid conjugate vaccine (TCV) in preventing …